Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

JANX

Janux Therapeutics Inc

May 12 • 04:00PM ET

14.41

+0.18 1.26 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS ALLO IOVA KYMR NRIX

| Held by: XBI VTI IWM VXF IBB IWN SCHA VTWO IWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.84	Insider Own	8.62%	Shs Outstand	60.87M	Perf Week	0.56%
Market Cap	878.78M	Forward P/E	-	EPS next Y	-2.77	Insider Trans	-0.49%	Shs Float	55.73M	Perf Month	-3.29%
Enterprise Value	-56.04M	PEG	-	EPS next Q	-0.31	Inst Own	101.18%	Short Float	14.23%	Perf Quarter	9.75%
Income	-114.48M	P/S	64.00	EPS this Y	-3.39%	Inst Trans	1.60%	Short Ratio	7.77	Perf Half Y	-45.58%
Sales	13.73M	P/B	0.93	EPS next Y	-46.45%	ROA	-11.01%	Short Interest	7.93M	Perf YTD	4.42%
Book/sh	15.47	P/C	0.92	EPS next 5Y	-23.03%	ROE	-11.72%	52W High	35.34 -59.22%	Perf Year	-44.70%
Cash/sh	15.68	P/FCF	-	EPS past 3/5Y	-6.44% -62.26%	ROIC	-11.92%	52W Low	12.12 18.89%	Perf 3Y	13.02%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.11% -	Gross Margin	85.59%	Volatility	3.75% 4.03%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-4.08	EPS Y/Y TTM	-35.51%	Oper. Margin	-1143.11%	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.01	Sales Y/Y TTM	47.10%	Profit Margin	-833.60%	RSI (14)	47.51	Recom	1.58
Dividend Gr. 3/5Y	- -	Current Ratio	17.01	EPS Q/Q	-2.21%	SMA20	-2.72%	Beta	2.56	Target Price	40.35
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	0.09%	Rel Volume	0.65	Prev Close	14.23
Employees	109	LT Debt/Eq	0.02	Earnings	May 07 AMC	SMA200	-25.52%	Avg Volume	1.02M	Price	14.41
IPO	Jun 11, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.17% -14.08%	Trades		Volume	665,927	Change	1.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)